Table 2. Recurrence and progression in the group of treated patients
Number of patients | 243 | |
---|---|---|
Recurrence | No | 144 (59%) |
Yes (all cases) | 99 (41%) | |
Yes (≤1 x/year) | 71 (29%) | |
Yes (>1 x/year) | 28 (11%) | |
Progression (all cases) | Yes | 45 ( 18%) |
Progression to muscle–invasive bladder cancer (MIBC) | Yes | 25 (10%) |